A Therapeutic Strategy to Target All Sources of IgE & Eliminate the Allergic Immune Response

Time: 9:00 am
day: Day Two


  • Immunoglobulin E (IgE) is a key driver of type 1 hypersensitivity reactions and allergic disorders, which are globally increasing in number and severity
  • Although eliminating pathogenic IgE may be a powerful way to treat allergy, no therapeutic strategy reported to date can fully ablate IgE production
  • We describe here a therapeutic approach to durably eliminate pathogenic IgE with potential to benefit allergy in human